Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey
Access
info:eu-repo/semantics/closedAccessDate
2022Author
Fıratlı Tuğlular, Ayşe TülinPehlivan, Mustafa
Sönmez, Mehmet
Kabukçu Hacıoğlu, Sibel
Saydam, Güray
Ayyıldız, Orhan
Kaynar, Leylagül
Demirkan, Fatih
Beksaç, Meral
Metadata
Show full item recordCitation
Fıratlı Tuğlular, A. T., Pehlivan, M., Sönmez, M., Kabukçu Hacıoğlu, S., Saydam, G., Ayyıldız, O. ... Beksaç, M. (2022). Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey. Clinical Lymphoma, Myeloma & Leukemia içinde (S190-S191. ss.).Abstract
...
WoS Q Kategorisi
Q3Source
Clinical Lymphoma, Myeloma & LeukemiaVolume
22Collections
- Bildiri Koleksiyonu [515]
- WoS İndeksli Yayınlar Koleksiyonu [6506]